XML 29 R16.htm IDEA: XBRL DOCUMENT v3.25.4
Investments
12 Months Ended
Dec. 31, 2025
Investments [Abstract]  
Investments Investments
 
Fixed maturity securities
See Note 6, "Fair Value" for additional fair value disclosures. The following tables summarize the amortized cost and estimated fair value, net of credit loss allowance, of our fixed maturity securities as of:
December 31, 2025
(in thousands)Amortized costGross unrealized gainsGross unrealized lossesEstimated fair value
Available-for-sale securities:
Corporate debt securities$834,885 $12,779 $3,185 $844,479 
Collateralized debt obligations133,224 207 164 133,267 
Commercial mortgage-backed securities139,516 2,808 1,783 140,541 
Residential mortgage-backed securities196,624 982 10,380 187,226 
Other debt securities34,863 543 254 35,152 
U.S. Treasury24,116 106 59 24,163 
Total available-for-sale securities, net (1)
1,363,228 17,425 15,825 1,364,828 
Held-to-maturity securities - states & political subdivisions4,833 3004,863 
Total fixed maturity securities, net$1,368,061 $17,455 $15,825 $1,369,691 

(1)     This includes an estimated fair value of $44.4 million of securities lent under a securities lending agreement.

December 31, 2024
(in thousands)Amortized costGross unrealized gainsGross unrealized lossesEstimated fair value
Available-for-sale securities:
Corporate debt securities$647,861 $4,767 $8,685 $643,943 
Collateralized debt obligations114,142 372 387 114,127 
Commercial mortgage-backed securities126,509 1,458 2,985 124,982 
Residential mortgage-backed securities150,212 62 16,462 133,812 
Other debt securities27,232 147 628 26,751 
Total available-for-sale securities, net (1)
1,065,956 6,806 29,147 1,043,615 
Held-to-maturity securities - states & political subdivisions4,833 1014,934 
Total fixed maturity securities, net$1,070,789 $6,907 $29,147 $1,048,549 

(1)     This includes an estimated fair value of $7.3 million of securities lent under a securities lending agreement.

The amortized cost and estimated fair value of our fixed maturity securities at December 31, 2025 are shown below by remaining contractual term to maturity. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

December 31, 2025
AmortizedEstimated
(in thousands)costfair value
Available-for-sale securities:
Due in one year or less $37,273 $37,302 
Due after one year through five years552,240 558,399 
Due after five years through ten years249,274 251,231 
Due after ten years524,441 517,896 
Total available-for-sale securities, net (1) (2)
1,363,228 1,364,828 
Held-to-maturity securities - due after ten years4,833 4,863 
Total fixed maturity securities, net$1,368,061 $1,369,691 

(1)    The contractual maturities of our available-for-sale securities are included in the table. However, given our intent to sell certain impaired securities, these securities are classified as current assets in our Consolidated Statement of Financial Position at December 31, 2025.
(2)    This includes an estimated fair value of $44.4 million of securities lent under a securities lending agreement.
The below securities have been evaluated for credit impairment using criteria described within Note 2, "Significant Accounting Policies". The gross unrealized losses are primarily attributable to changes in interest rates and are not deemed to be credit-related. We do not have the intent to sell these securities and it is more likely than not that we would not be required to sell these securities before the anticipated recovery of the amortized cost basis.

The following tables present available-for-sale securities based on length of time in a gross unrealized loss position as of:
December 31, 2025
Less than 12 months12 months or longerTotal
(dollars in thousands)Fair
value
Unrealized lossesFair
value
Unrealized lossesFair
value
Unrealized lossesNo. of holdings
Corporate debt securities$72,699 $1,555 $41,040 $1,630 $113,739 $3,185 418 
Collateralized debt obligations57,917 120 3,909 44 61,826 164 83 
Commercial mortgage-backed securities16,103 59 19,956 1,724 36,059 1,783 70 
Residential mortgage-backed securities17,675 27 92,019 10,353 109,694 10,380 146 
Other debt securities3,936 39 3,655 215 7,591 254 27 
U.S. Treasury13,296 59 13,296 59 
Total available-for-sale securities$181,626 $1,859 $160,579 $13,966 $342,205 $15,825 747 
Quality breakdown of available-for-sale securities:       
Investment grade$144,472 $433 $144,604 $12,773 $289,076 $13,206 371 
Non-investment grade37,154 1,426 15,975 1,193 53,129 2,619 376 
Total available-for-sale securities$181,626 $1,859 $160,579 $13,966 $342,205 $15,825 747 


December 31, 2024
Less than 12 months12 months or longerTotal
(dollars in thousands)Fair
value
Unrealized lossesFair
value
Unrealized lossesFair
value
Unrealized lossesNo. of holdings
Corporate debt securities$197,619 $2,486 $156,059 $6,199 $353,678 $8,685 567 
Collateralized debt obligations33,686 71 11,762 316 45,448 387 77 
Commercial mortgage-backed securities28,333 407 24,966 2,578 53,299 2,985 131 
Residential mortgage-backed securities38,003 1,289 90,209 15,173 128,212 16,462 169 
Other debt securities11,663 150 5,045 478 16,708 628 42 
Total available-for-sale securities$309,304 $4,403 $288,041 $24,744 $597,345 $29,147 986 
Quality breakdown of available-for-sale securities:       
Investment grade$280,332 $3,701 $260,480 $22,664 $540,812 $26,365 616 
Non-investment grade28,972 702 27,561 2,080 56,533 2,782 370 
Total available-for-sale securities$309,304 $4,403 $288,041 $24,744 $597,345 $29,147 986 


Credit loss allowances
The following tables present a roll-forward of the allowances for credit losses on investments for the years ended December 31:
2025
(in thousands)Available-for-sale securitiesHeld-to-maturity securities
Other loans receivable
Agent loans
Balance, beginning of period$513 $2,167 $12,198 $1,312 
Provision and recoveries1,389 2,928 368 
Sales/collections and write-offs(1,000)(25)
Balance, end of period$902 $2,167 $15,101 $1,680 

2024
(in thousands)Available-for-sale securitiesHeld-to-maturity securities
Other loans receivable
Agent loans
Balance, beginning of period$597 $$11,081 $957 
   Provision and recoveries484 2,167 1,117 355 
   Sales/collections and write-offs(568)
Balance, end of period$513 $2,167 $12,198 $1,312 
Net investment income
Investment income (loss), net of expenses, was generated from the following portfolios for the years ended December 31:
(in thousands)202520242023
Available-for-sale securities$57,093 $49,605 $42,563 
Equity securities4,637 4,758 4,493 
Limited partnerships (1)
3,549 1,971 (11,308)
Agent loans (2)
6,417 4,368 3,236 
Cash equivalents and other (2)
16,551 11,093 5,943 
Total investment income88,247 71,795 44,927 
Less: investment expenses2,410 1,640 355 
Net investment income$85,837 $70,155 $44,572 
(1)    Limited partnership income (losses) include both realized gains (losses) and unrealized valuation changes. Our limited partnership investments are included in the line item "Other assets, net" in the Consolidated Statements of Financial Position. We have made no new significant limited partnership commitments since 2006, and the balance of limited partnership investments is expected to decline over time as additional distributions are received.
(2)    2024 and 2023 amounts have been reclassified to conform to the current period presentation.


Net realized and unrealized investment gains (losses)
Realized and unrealized gains (losses) on investments were as follows for the years ended December 31:
(in thousands)202520242023
Available-for-sale securities:
Gross realized gains$2,891 $3,415 $804 
Gross realized losses(2,838)(5,035)(7,523)
Net realized gains (losses) on available-for-sale securities53 (1,620)(6,719)
Equity securities2,278 4,848 871 
Miscellaneous10 
Net realized and unrealized investment gains (losses)$2,336 $3,229 $(5,838)


The portion of net unrealized gains (losses) recognized during the reporting period related to equity securities held at the reporting date is calculated as follows for the years ended December 31:
(in thousands)202520242023
Equity securities:
Net gains recognized during the period$2,278 $4,848 $871 
Less: net gains (losses) recognized on securities sold341 1,213 (2,328)
Net unrealized gains recognized on securities held at reporting date$1,937 $3,635 $3,199 


Net impairment losses recognized in earnings
Impairments on investments were as follows for the years ended December 31:
(in thousands)202520242023
Available-for-sale securities:
Intent to sell$(495)$(299)$(1,759)
Credit impaired(1,389)(484)(670)
Total available-for-sale securities(1,884)(783)(2,429)
Expected credit losses:
Held-to-maturity securities(2,167)— 
Agent loans(368)(355)
Other loans receivable
(1,060)(819)(7,337)
Net impairment losses recognized in earnings$(3,312)$(4,124)$(9,766)
Securities lending transactions
As of December 31, 2025, the estimated fair value of loaned securities was $64.5 million, consisting of $44.4 million of available-for sale securities and $20.1 million of equity securities. As of December 31, 2024, the estimated fair value of loaned securities was $7.3 million, consisting of available-for-sale securities. Cash collateral received in connection with these securities lending transactions totaled $61.9 million and $7.5 million as of December 31, 2025 and 2024, respectively. The cash collateral was reinvested in cash equivalents and is included in "Cash and cash equivalents" in the Consolidated Statements of Financial Position. As of December 31, 2025, we also received $4.5 million of non-cash collateral, which we are not permitted to sell or repledge. There were no securities lending transactions outstanding with contractual maturities extending beyond one year from the reporting date.

If we have to return cash collateral on short notice, we may have difficulty selling investments in a timely manner, be forced to sell them for less than we otherwise would have been able to realize, or both. In addition, in the event of such forced sale, for securities in an unrealized loss position, realized losses would be incurred on securities sold and impairments would be incurred, if there is a need to sell securities prior to recovery, which may negatively impact our financial condition.